Platelet-derived biologic C-1101 for chronic sciatica.
概要
Consano Bio is a clinical-stage biotech company in Burlington, Massachusetts. Its lead candidate C-1101 is a platelet-derived multi-protein biologic delivered by epidural injection for chronic painful lumbosacral radiculopathy. It is in a Phase 1 trial and received FDA Fast Track designation in August 2026.